SCHEMBL9516970

SCHEMBL9516970

CCCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(COCc3ccccc3)nc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL2L1 Q07817 6/20 0.48
▸ MCL1 Q07820 6/20 0.48
▸ P4HTM Q9NXG6 4/20 0.47
▸ KMT2A Q03164 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ HDAC3 O15379 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ NCOR2 Q9Y618 1/20 0.42
▸ NPC1 O15118 3/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41
▸ RELA Q04206 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ SCN3A Q9NY46 1/20 0.41
▸ EGFR P00533 1/20 0.41
▸ SCN9A Q15858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9517291 0.94 BCL2L1 (0.47) BCL2L1MCL1P4HTMKMT2AHDAC3
SCHEMBL9518145 0.88 P4HTM (0.61) BCL2L1MCL1P4HTMEGFR
SCHEMBL9515759 0.85 P4HTM (0.58) BCL2L1MCL1P4HTMNPC1RAB9A
SCHEMBL9516250 0.83 CA2 (0.46) P4HTMKMT2AKDM4ENPC1RAB9A
SCHEMBL9517308 0.83 ALDH1A1 (0.50) BCL2L1MCL1P4HTMKMT2ANPC1
SCHEMBL9515549 0.82 KDM4E (0.52) P4HTMKMT2AKDM4ESMN1; SMN2NFKB1
SCHEMBL9515987 0.82 NPC1 (0.49) BCL2L1MCL1P4HTMKMT2AHDAC2
SCHEMBL9515532 0.81 P4HTM (0.61) BCL2L1MCL1P4HTMEGFR
SCHEMBL9516137 0.81 HDAC3 (0.45) P4HTMKMT2AHDAC3HDAC1HDAC2
SCHEMBL9517102 0.81 NPC1 (0.49) BCL2L1MCL1P4HTMKMT2AHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 — — EP disclosed
Send feedback